Options
GANNET53: AN UPCOMING CLINICAL TRIAL BASED ON A DRUG STRATEGY TARGETING STABILISED MUTANT P53 TO COMBAT PLATINUM-RESISTANT OVARIAN CANCER
Date Issued
2013
Author(s)
Concin, Nicole
Braicu, Elena Ioana
Mahner, Sven
Marth, Christian
Pujade-Lauraine, Eric
Ray-Coquard, Isabelle
Sehouli, Jalid
Vergote, Ignace
Zeillinger, R.